Recherche
-
Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis
(Multiple Sclerosis and Related Disorders. vol. 57, pp. 103385, 2022-01)Article de revueLibre accès -
High B-value diffusion tensor imaging for early detection of hippocampal microstructural alteration in a mouse model of multiple sclerosis
(Scientific Reports. vol. 12, n° 1, pp. 12008, 2022-07-14)Article de revueLibre accès -
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice
(Nature Metabolism. vol. 4, n° 8, pp. 1071-1083, 2022-08-04)Article de revueLibre accès -
The Challenging Management of Craniopharyngiomas in Adults: Time for a Reappraisal?
(Cancers. vol. 14, n° 15, pp. 3831, 2022-08-07)Article de revueLibre accès -
The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models
(Neuroscience and Biobehavioral Reviews. vol. 132, pp. 664-678, 2022-01)Article de revueLibre accès -
Structure-function coupling as a correlate and potential biomarker of cognitive impairment in multiple sclerosis
(Network Neuroscience. vol. 6, n° 2, pp. 339-356, 2022-06-01)Article de revueLibre accès -
Le récepteur hypothalamique TGR5 des acides biliaires : une cible thérapeutique pour lutter contre l’obésité ?
(2022)Document de travail - Pré-publicationLibre accès -
Brain imaging determinants of functional prognosis after severe endocarditis: a multicenter observational study
(Neurological Sciences. vol. 43, n° 6, pp. 3759-3768, 2022-06)Article de revueLibre accès -
The Role of MicroRNA and Microbiota in Depression and Anxiety
(Frontiers in Behavioral Neuroscience. vol. 16, 2022-03-01)Article de revueLibre accès -
NOS1 mutations cause hypogonadotropic hypogonadism with sensory and cognitive deficits that can be reversed in infantile mice
(Science Translational Medicine. vol. 14, n° 665, 2022-10-05)Article de revueLibre accès